Insmed (INSM) Cash from Operations (2010 - 2026)

Insmed has reported Cash from Operations for 17 years, with the latest figure at -$88.8 million in Q2 2026.

• On a quarterly basis, Cash from Operations rose 56.79% year-over-year to -$88.8 million in Q2 2026; TTM through Jun 2026 was -$778.9 million, a 7.77% increase from a year earlier, with the FY2025 full-year figure at -$935.0 million, down 36.72% from the prior year.
• Cash from Operations was -$88.8 million for Q2 2026 at Insmed, up from -$222.7 million in the prior quarter.
• The five-year high for Cash from Operations was -$88.8 million in Q2 2026, with the low at -$262.1 million in Q1 2025.
• Average Cash from Operations over 5 years is -$159.3 million, with a median of -$141.3 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Cash from Operations slumped 67.19% in 2025, then soared 56.79% in 2026.
• Over 5 years, Cash from Operations stood at -$103.1 million in 2022, then retreated by 26.83% to -$130.8 million in 2023, then tumbled by 49.81% to -$196.0 million in 2024, then fell by 26.34% to -$247.6 million in 2025, then jumped by 64.12% to -$88.8 million in 2026.
• The last three Cash from Operations figures came in at -$88.8 million (Q2 2026), -$222.7 million (Q1 2026), and -$247.6 million (Q4 2025), per Business Quant data.